Palomino Laboratories Inc.
PALX · OTCMCIK 1938569fmd_1J3DAPRFQWGK2Y1R3MGFFZ8YMYManufacturing · Semiconductors & Related DevicesTemplate: Standard
Coverage: Jan 01, 2022 to Jun 30, 2026, 16 periods
Latest annual · FY2025
Millions- Operating income
- (3)
- Net income
- (3)
Latest quarter · Q2 FY2026
Millions- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (2)
Palomino Laboratories Inc. (PALX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2.7 million | -$6,123 | 10-K 2026-03-31 · proof | |
| Net income | -$3.2 million | -$16,198 | 10-K 2026-03-31 · proof | |
| Cash from operating activities | -$1.3 million | -$4,870 | 10-K 2026-03-31 · proof | |
| Total assets | $8.4 million | $138,125 | +6,006.2% | 10-K 2026-03-31 · proof |
| Total liabilities | $336,458 | $156,431 | +115.1% | 10-K 2026-03-31 · proof |
| Cash and cash equivalents | $8.1 million | $134,657 | +5,931.2% | 10-K 2026-03-31 · proof |
- What was Palomino Laboratories Inc. (PALX)'s operating income in fiscal 2025?
- Palomino Laboratories Inc. (PALX) reported operating income of -$2.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$6,123 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Palomino Laboratories Inc. (PALX)'s net income in fiscal 2025?
- Palomino Laboratories Inc. (PALX) reported net income of -$3.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$16,198 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Palomino Laboratories Inc. (PALX)'s cash from operating activities in fiscal 2025?
- Palomino Laboratories Inc. (PALX) reported cash from operating activities of -$1.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$4,870 the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Palomino Laboratories Inc. (PALX)'s total assets?
- As of Dec 31, 2025, Palomino Laboratories Inc. (PALX) reported total assets of $8.4 million, against $138,125 a year earlier (+6,006.2%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Palomino Laboratories Inc. (PALX)'s total liabilities?
- As of Dec 31, 2025, Palomino Laboratories Inc. (PALX) reported total liabilities of $336,458, against $156,431 a year earlier (+115.1%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Palomino Laboratories Inc. (PALX)'s cash and cash equivalents?
- As of Dec 31, 2025, Palomino Laboratories Inc. (PALX) reported cash and cash equivalents of $8.1 million, against $134,657 a year earlier (+5,931.2%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PALX&period_type=annual&limit=5"Information only, not investment advice.